Patents
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
04/2004
04/15/2004US20040072209 Methods of labelling polynucleotides with dibenzorhodamine dyes
04/15/2004US20040072206 Screening for enzyme inhibitor to prevent microorganismal propagation; bactericides; antibiotic
04/15/2004US20040072204 Base sequence cluster generating system, base sequence cluster generating method, program for performing cluster generating method, and computer readable recording medium on which program is recorded and system for providing base sequence Information
04/15/2004US20040072203 After extension of the primer using a polymerase, primer-extension product is complexed with a solid support to which is attached an arylboronic acid complexing group, separation of resulting complex from reaction mixture
04/15/2004US20040072194 Vasodilation polypeptide for diagnosis and treatment of vascular and cardiovascular system disorders
04/15/2004US20040072193 Detecting gene expression in cells, comprising trapping cell on filter or membrane, contacting cell with membrane permeation solution, dissolving membrane, recovering and analyzing messenger RNA using oligonuclelotide column
04/15/2004US20040072189 Diagnosing cancer via presence of osteopontin in epithelial cells; genetic vaccines; antitumor agents
04/15/2004US20040072188 Comprises nucleotide sequences coding B-cell activating factor receptor (BAFF-R) for diagnosis, prevention, treatment and/or delay of cancers, lymphomas and autoimmune diseases
04/15/2004US20040072186 Transglutaminase gene products
04/15/2004US20040072185 Cellular genes involved in oncogenesis, products of said genes and their diagnostic and therapeutic uses
04/15/2004US20040072184 Cancer associated protein kinases and their uses
04/15/2004US20040072180 Dna binding peptide domains and a method for providing domains of this type
04/15/2004US20040072178 Genes encoding proteins capable of regenerating luciferin, recombinant dna and process for producng protein capable of regenerating luciferin
04/15/2004US20040072177 Novel human serine-threonine kinase
04/15/2004US20040072176 Used to detect the presence of a target nucleic acid in a sample solution, eg to identify whether a patient is infected with a disease causing microorganism such as Chlamydia trachomatis
04/15/2004US20040072174 Calpain protease 12
04/15/2004US20040072172 Comprises enzymatic polypeptide associated with calcium dependent movement of phospholipids through plasmid membranes for diagnosis and treatment of thrombosis, angina pectoris and stroke; gene therapy
04/15/2004US20040072171 Screening for regulatory factors of neurofibromatosis (NF2); antitumor agents
04/15/2004US20040072170 Using creatine kinase messenger RNA expression profiles to diagnose congestive heart failure
04/15/2004US20040072169 Comprises nucleotide sequences coding polypeptide for exogenous expression in avian embryonic stem cells; bioreactors
04/15/2004US20040072168 Novel deoxynucleoside kinase enzyme variants
04/15/2004US20040072165 Method for producing dna encoding polypeptides that are composed of several section, and for producing polypeptides by expressing the dna thus obtained
04/15/2004US20040072164 Using nested oligonucleotide to propagate preferential nucleic acids for detection, identification, quantification and analysis of mutant genotypes; drug resistance; pharmacogenomics
04/15/2004US20040072159 Bzip type transcription factors regulating the expression of rice storage protein
04/15/2004US20040072156 Detecting allelic variation in nuceotide sequences for use in rational drug design and screening; gene therapy and diseases diagnosis
04/15/2004US20040072155 Molecular methods for detecting guar gum additions to locust bean gum
04/15/2004US20040072154 Novel compositions and methods for cancer
04/15/2004US20040072152 Screening blood and identifying immunologically active antigen of herpes simplex virus (HSV) which attacks skin; diagnosing viral infection; viricides
04/15/2004US20040072151 Method of extracting virus genes and extraction apparatus
04/15/2004US20040072150 Identification of oligonucleotides for the capture, detection and quantitation of hepatitis A viral nucleic acid
04/15/2004US20040072147 Using oligonucleotide to screen for presence of drug resistant DNA viruses in fluids
04/15/2004US20040072145 Using oligonucleotides to detect viral nucleotide sequences in food; diagnosing food poisoning
04/15/2004US20040072142 Used for a screening method for inhibitors of enzymes of the pathway, and a method for identifying inhibitor-resistant variants
04/15/2004US20040072141 Producing semen via xenogenic tissue grafting of testis in animal models; preserving fertility in prepubescent males undergoing chemotherapeutic treatment
04/15/2004US20040071853 For improving rheological properties of a flour dough and the quality of bread, alimentary paste products, noodles and cakes
04/15/2004US20040071733 Baculovirus vector vaccine
04/15/2004US20040071731 Chimeric protein comprising non-toxic pseudomonas exotoxin a and type iv pilin sequences
04/15/2004US20040071730 Polypeptides and polynucleotides; genetic engineering; medical diagnosis
04/15/2004US20040071729 Comprising amino acid sequences of streptococcal matrix adhesion (Ema) polypeptides
04/15/2004US20040071725 Administered with target antigens to treat infections; anticarcinogenic and antitumor agents; genetic engineering
04/15/2004US20040071724 Heat shock protein-based vaccines and immunotherapies
04/15/2004US20040071721 A fusion protein of antigen and heat shock protein; DNA therapy promoting gene expression in mammal cells, treating infectious diseases and cancers, tumors; polynucleotide construct vectors
04/15/2004US20040071720 A fusion protein of antigen and heat shock protein; DNA therapy promoting gene expression in mammal cells, treating infectious diseases and cancers, tumors; polynucleotide construct vectors
04/15/2004US20040071717 Recombinant DNA encoding the major allergen of plantago lanceolata pollen, Pla I 1, and applications thereof
04/15/2004US20040071714 A gene expressed polypeptide is used in food, for treating food allergy
04/15/2004US20040071713 A protein is obtained from gene expression of Pseudomonas aeruginosa, molecular weight range from 13 kDa to 80 kDa, purification, antibody, immunization with vaccine antigens, treating bacterial infections
04/15/2004US20040071712 Modified peptides as therapeutic agents
04/15/2004US20040071711 Imaging, diagnosis and treatment of disease
04/15/2004US20040071710 Human monoclonal antibody against hepatitis c virus e2 glycoprotein
04/15/2004US20040071709 Corona-virus-like particles comprising functionally deleted genomes
04/15/2004US20040071704 Antithrombotic von willebrand factor (vwf) collagen bridging blockers
04/15/2004US20040071702 Homologous recombination, heavy chain peptides, amino acid sequences, light chain peptides, for treating inflammatory disorders, rheumatoid arthritis, psoriasis, transplant rejections and cancers
04/15/2004US20040071699 An antagonists, or agonists, producing antibodies, used as immunotherapy treating allergy, acquired immune deficiency syndrome, autoimmune diabetes, thyroiditis
04/15/2004US20040071698 Human anti-epidermal growth factor receptor single-chain antibodies
04/15/2004US20040071695 Novel g-protein coupled receptor
04/15/2004US20040071693 Humanised antibodies
04/15/2004US20040071692 Minimizes toxicity to normal tissue; high therapeutic index
04/15/2004US20040071690 High avidity polyvalent and polyspecific reagents
04/15/2004US20040071688 Reduced or removed potential T cell epitopes
04/15/2004US20040071686 Treatment of alpha-galactosidase A deficiency
04/15/2004US20040071678 Method of producing genetically modified astrocytes and uses thereof
04/15/2004US20040071677 Nephritis treatment by gene therapy
04/15/2004US20040071676 Yeast expression vector and a method of making a recombinant protein by expression in a yeast cell
04/15/2004US20040071673 Construction and use of genes encoding pathogenic epitopes for treatment of autoimmune disease
04/15/2004US20040071670 Transplantation cell kits for re-myelination of nerve cells
04/15/2004US20040071669 Transplants for myocardial scars
04/15/2004US20040071661 Synthetic viruses and uses thereof
04/15/2004US20040071660 Fiber protein of seretype 11, 16, 35, 40 and/or 51; efficient transduction; nucleic acid transfer
04/15/2004US20040071658 Vaccine immunotherapy for immune suppressed patients
04/15/2004US20040071656 Modulation of heat-shock-protein-based immunotherapies
04/15/2004US20040071655 Binding agent
04/15/2004US20040071654 Delivering labile agents; buffering effect; transfecting nucleic acids; nontoxic
04/15/2004US20040071647 Using tissue inhibitor of metalloproteases (TIMP)
04/15/2004US20040071595 Computer-based control unit; a variable-speed centrifuge having an openable vacuum-tight chamber and a centrifuge rotor with multi-sample holding positions, a liquid solvent supply subsystem; vacuum subsystem
04/15/2004US20040069656 Apparatus and method for analysing chemical samples
04/15/2004DE10246186A1 In vitro or in vivo degradation or synthesis of silicon dioxide and silicones, useful e.g. for treating silicosis or to prepare prosthetic materials, using a new silicase enzyme
04/15/2004DE10246125A1 Konzentrat eines Faktor VIII:C-haltigen von-Willebrand-Faktors und das dazu gehörige Verfahren Concentrate of factor VIII: C-containing von Willebrand factor and the associated method
04/15/2004DE10238434A1 Verfahren zur Identifizierung von Substanzen mit herbizider Wirkung A method for identifying herbicidally active substances
04/15/2004CA2501958A1 Polynucleotides and polypeptides derived from lactobacillus rhamnosus hn001
04/15/2004CA2501218A1 High yield heterologous expression cell lines for expression of gene products with human glycosylation pattern
04/15/2004CA2501068A1 Human artificial chromosome (hac) vector
04/15/2004CA2501061A1 Protein labelling with o6-alkylguanine-dna alkyltransferase
04/15/2004CA2501030A1 Method and kit for quantitative and qualitative determination of human papillomavirus
04/15/2004CA2501010A1 Targeted tumor therapy by use of recombinant adenovirus vectors that selectively replicate in hypoxic regions of tumors
04/15/2004CA2501000A1 High sensitivity quantitation of peptides by mass spectrometry
04/15/2004CA2500955A1 Optimized multi-epitope constructs and uses thereof
04/15/2004CA2500883A1 Mouse-origin proteins forming domain or use thereof
04/15/2004CA2500673A1 Hbv mutations associated with reduced susceptibility to adefovir
04/15/2004CA2500661A1 Anti-cancer and anti-infectious disease compositions and methods for using same
04/15/2004CA2500470A1 Method for diagnosing chronic myeloid leukemia
04/15/2004CA2500405A1 Genes and polypeptides relating to human myeloid leukemia
04/15/2004CA2500151A1 Ttk protein kinase gene for diagnosing and treating non-small cell lung cancers
04/15/2004CA2500093A1 Dna vaccine encoding at least two nonstructural early proteins of papillomavirus
04/15/2004CA2499871A1 Orthopoxvirus vectors, genes and products thereof
04/15/2004CA2499483A1 Novel chemokine-like polypeptides
04/15/2004CA2499477A1 Prevention of primary sjogren's syndrome by ica69 deficiency
04/15/2004CA2498854A1 Novel mhc ii associated peptides
04/15/2004CA2498631A1 Use of a33 antigens and jam-it
04/15/2004CA2498026A1 Compositions for treatment of prostate and other cancers
04/15/2004CA2497649A1 Apparatus and method for streaming electroporation